Edition:
India

ViiV Healthcare Says To Develop Investigational Antibody N6lS For Treatment Of HIV-1


Thursday, 21 Nov 2019 

Nov 21 (Reuters) - ViiV Healthcare: :VIIV HEALTHCARE - TO DEVELOP INVESTIGATIONAL BROADLY NEUTRALISING ANTIBODY N6LS FOR TREATMENT AND PREVENTION OF HIV-1.VIIV HEALTHCARE - DEVELOPMENT OF INVESTIGATIONAL BNAB PART OF LICENSING DEAL BETWEEN GSK, NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES.VIIV HEALTHCARE - TO INITIATE A PHASE IIA STUDY WITH MATERIAL MANUFACTURED BY NIAID VACCINE RESEARCH CENTER.